Vivos Therapeutics Inc. announced the immediate exercise of certain outstanding warrants to purchase up to 1,982,356 shares of common stock at a reduced exercise price of $2.34 per share, generating approximately $4.64 million in gross proceeds. In connection with this, the company will issue new unregistered warrants in a private placement to purchase up to 3,964,712 shares of common stock at an exercise price of $2.09 per share. The new warrants will be immediately exercisable, with half expiring in five years and the other half in twenty-four months. Net proceeds will be used for working capital and general corporate purposes. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9626945-en) on January 16, 2026, and is solely responsible for the information contained therein.